These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 33870828)

  • 1. Secondary enucleated retinoblastoma with MYCN amplification.
    Moulin AP; Stathopoulos C; Marcelli F; Schoumans Pouw J; Beck-Popovic M; Munier FL
    Ophthalmic Genet; 2021 Jun; 42(3):354-359. PubMed ID: 33870828
    [No Abstract]   [Full Text] [Related]  

  • 2.
    Price EA; Patel R; Scheimberg I; Kotiloglu Karaa E; Sagoo MS; Reddy MA; Onadim Z
    Ophthalmic Genet; 2021 Oct; 42(5):604-611. PubMed ID: 34003079
    [No Abstract]   [Full Text] [Related]  

  • 3. Next-Generation Sequencing of Retinoblastoma Identifies Pathogenic Alterations beyond RB1 Inactivation That Correlate with Aggressive Histopathologic Features.
    Afshar AR; Pekmezci M; Bloomer MM; Cadenas NJ; Stevers M; Banerjee A; Roy R; Olshen AB; Van Ziffle J; Onodera C; Devine WP; Grenert JP; Bastian BC; Solomon DA; Damato BE
    Ophthalmology; 2020 Jun; 127(6):804-813. PubMed ID: 32139107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MRI Features for Identifying
    Jansen RW; de Bloeme CM; Cardoen L; Göricke S; van Elst S; Jessen JL; Ramasubramanian A; Skalet AH; Miller AK; Maeder P; Uner OE; Hubbard GB; Grossniklaus H; Boldt HC; Nichols KE; Brennan RC; Sen S; Sirin S; Brisse HJ; Galluzzi P; Dommering CJ; Castelijns JA; van der Valk P; Boellaard R; Dorsman J; Moll AC; de Jong MC; de Graaf P
    Radiology; 2023 Jun; 307(5):e222264. PubMed ID: 37191489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylation of pRb: mechanism for RB pathway inactivation in MYCN-amplified retinoblastoma.
    Ewens KG; Bhatti TR; Moran KA; Richards-Yutz J; Shields CL; Eagle RC; Ganguly A
    Cancer Med; 2017 Mar; 6(3):619-630. PubMed ID: 28211617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous identification of clinically relevant
    Xu L; Shen L; Polski A; Prabakar RK; Shah R; Jubran R; Kim JW; Biegel J; Kuhn P; Cobrinik D; Hicks J; Gai X; Berry JL
    Ophthalmic Genet; 2020 Dec; 41(6):526-532. PubMed ID: 32799607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive characterization of RB1 mutant and MYCN amplified retinoblastoma cell lines.
    Schwermer M; Hiber M; Dreesmann S; Rieb A; Theißen J; Herold T; Schramm A; Temming P; Steenpass L
    Exp Cell Res; 2019 Feb; 375(2):92-99. PubMed ID: 30584916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of high level E2F in a RB1 proficient MYCN overexpressing chicken retinoblastoma model normalizes neoplastic behaviour.
    Zhang H; Konjusha D; Rafati N; Tararuk T; Hallböök F
    Cell Oncol (Dordr); 2024 Feb; 47(1):209-227. PubMed ID: 37606819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterisation of retinoblastomas without RB1 mutations: genomic, gene expression, and clinical studies.
    Rushlow DE; Mol BM; Kennett JY; Yee S; Pajovic S; Thériault BL; Prigoda-Lee NL; Spencer C; Dimaras H; Corson TW; Pang R; Massey C; Godbout R; Jiang Z; Zacksenhaus E; Paton K; Moll AC; Houdayer C; Raizis A; Halliday W; Lam WL; Boutros PC; Lohmann D; Dorsman JC; Gallie BL
    Lancet Oncol; 2013 Apr; 14(4):327-34. PubMed ID: 23498719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic cfDNA Analysis of Aqueous Humor in Retinoblastoma Predicts Eye Salvage: The Surrogate Tumor Biopsy for Retinoblastoma.
    Berry JL; Xu L; Kooi I; Murphree AL; Prabakar RK; Reid M; Stachelek K; Le BHA; Welter L; Reiser BJ; Chévez-Barrios P; Jubran R; Lee TC; Kim JW; Kuhn P; Cobrinik D; Hicks J
    Mol Cancer Res; 2018 Nov; 16(11):1701-1712. PubMed ID: 30061186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-Risk Histopathology Features in Primary and Secondary Enucleated International Intraocular Retinoblastoma Classification Group D Eyes.
    Fabian ID; Stacey AW; Chowdhury T; Duncan C; Karaa EK; Scheimberg I; Reddy MA; Sagoo MS
    Ophthalmology; 2017 Jun; 124(6):851-858. PubMed ID: 28302322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel de-novo RB1 mutation identified in a patient with bilateral retinoblastoma.
    Fukushima H; Suzuki R; Hiraoka T; Suzuki S; Noguchi E; Takada H
    Jpn J Clin Oncol; 2023 Aug; 53(9):863-865. PubMed ID: 37345682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ectopic intracranial retinoblastoma in a 3.5-month-old infant without eye involvement and without evidence of heritability.
    Römer T; Temming P; Lohmann DR; Sturm D; von Deimling A; Sellhaus B; Mull M; Kontny U; Moser O
    Pediatr Blood Cancer; 2019 May; 66(5):e27599. PubMed ID: 30604586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Genetic analysis results of patients with a retinoblastoma refractory to systemic chemotherapy].
    Ruiz del Río N; Abelairas Gómez JM; Alonso García de la Rosa FJ; Peralta Calvo JM; de las Heras Martín A
    Arch Soc Esp Oftalmol; 2015 Sep; 90(9):414-20. PubMed ID: 25817468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutant-RB1 circulating tumor DNA in the blood of unilateral retinoblastoma patients: What happens during enucleation surgery: A pilot study.
    Abramson DH; Mandelker DL; Brannon AR; Dunkel IJ; Benayed R; Berger MF; Arcila ME; Ladanyi M; Friedman DN; Jayakumaran G; Diosdado MS; Robbins MA; Haggag-Lindgren D; Shukla N; Walsh MF; Kothari P; Tsui DWY; Francis JH
    PLoS One; 2023; 18(2):e0271505. PubMed ID: 36735656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic and Transcriptomic Tumor Heterogeneity in Bilateral Retinoblastoma.
    Winter U; Ganiewich D; Ottaviani D; Zugbi S; Aschero R; Sendoya JM; Cafferata EG; Mena M; Sgroi M; Sampor C; Lubieniecki F; Fandiño A; Abba MC; Doz F; Podhjacer O; Carcaboso AM; Letouzé E; Radvanyi F; Chantada GL; Llera AS; Schaiquevich P
    JAMA Ophthalmol; 2020 May; 138(5):569-574. PubMed ID: 32191268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A MYCN-driven de-differentiation profile identifies a subgroup of aggressive retinoblastoma.
    Ryl T; Afanasyeva E; Hartmann T; Schwermer M; Schneider M; Schröder C; Wagemanns M; Bister A; Kanber D; Steenpass L; Schramm K; Jones B; Jones DTW; Biewald E; Astrahantseff K; Hanenberg H; Rahmann S; Lohmann DR; Schramm A; Ketteler P
    Commun Biol; 2024 Jul; 7(1):919. PubMed ID: 39079981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bilateral retinoblastoma with one eye manifesting only posterior chamber infiltration and no retinal involvement.
    Ossandon D; Kastner A; Zanolli M; Solanes F; Pérez V; Repetto G; Benavides F; Shields CL
    J AAPOS; 2016 Dec; 20(6):548-550.e1. PubMed ID: 27815188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathological findings in enucleated eyes after intravitreal melphalan injection.
    Ghassemi F; Amoli FA
    Int Ophthalmol; 2014 Jun; 34(3):533-40. PubMed ID: 24043335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A histopathologic analysis of 50 eyes primarily enucleated for retinoblastoma in a tertiary cancer center in Jordan.
    Yousef YA; Hajja Y; Nawaiseh I; Mehyar M; Sultan I; Deebajah R; Rawashdeh K; Khurma S; Jaradat I; Al-Hussaini M
    Turk Patoloji Derg; 2014; 30(3):171-7. PubMed ID: 24913302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.